Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
10.09
+0.05 (0.50%)
At close: Jan 16, 2026, 4:00 PM EST
10.07
-0.02 (-0.20%)
After-hours: Jan 16, 2026, 4:00 PM EST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $882.67 million as of January 16, 2026. Its market cap has increased by 134.39% in one year.
Market Cap
882.67M
Enterprise Value
943.43M
1-Year Change
134.39%
Ranking
Category
Stock Price
$10.09
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $882.67M, an increase of 95.74%. That is a compound annual growth rate of 5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 882.67M | 17.04% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |